MedPage Today on MSN
Color blindness and bladder cancer: A bad combination for survival?
People with color vision deficiency -- commonly known as color blindness -- may have a higher risk of mortality from bladder ...
ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
Wits scientists have identified a "microbial watchlist" of bacteria, viruses, fungi and parasites that could cause cancer.
I was living a normal 29-year-old life. I thought my symptoms were no big deal, until they started happening more ...
Detailed price information for Biovaxys Technology Corp (BIOV-CN) from The Globe and Mail including charting and trades.
ImmunityBio’s Anktiva receives Saudi FDA approval for non-muscle invasive bladder cancer with carcinoma in-situ: Culver City, California Friday, January 16, 2026, 15:00 Hrs [IST ...
Xtandi, Astellas’ roughly $6 billion prostate cancer juggernaut by annual sales, is set to lose U.S. patent protection in ...
The key drivers of increased investor interest in AstraZeneca are the strong performance of its oncology and cardiovascular ...
The preventive immunization Nous-209 works in an initial trial with patients who have 17 times the risk of developing tumors ...
ImmunityBio, Inc. ( IBRX) 44th Annual J.P. Morgan Healthcare Conference January 11, 2026 7:00 PM EST ...
NanOlogy, LLC, a clinical-stage oncology company, today announced the appointment of John M. Goldberg, MD as fractional Chief Medical Officer (CMO) to advance development of its Large Surface Area ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback